Dear NNPDF Families and Friends,
On the 23rd day of our 2014 October GLOBAL NPD Awareness month event, we're taking the time to give special recognition to our NNPDF family efforts and how our families have brought us to this new threshold of therapeutic treatments for both Niemann-Pick Type C, as well as, acid sphingomyelinase deficiency (ASMD).
The members of the National Niemann-Pick Disease Foundation would like to offer a genuine note of thanks and heartfelt gratitude to the many individuals, families, community members, advocacy groups, as well as, esteemed members of the research and scientific community who all came together in a truly collaborative effort to see this process through to the below clinical trials.
The kindness and generosity of the Niemann-Pick Disease Community ensures that essential research and clinical trials will continue as we Persevere in our quest for a cure!
Visit the NNPDF Web page to see all the most recent updates on current NPD Clinical Trials: http://www.nnpdf.org/NewsLinePage.html#Oct23